共 185 条
[1]
Moertel CG(1992)Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma N. Engl. J. Med. 326 519-523
[2]
Lefkopoulo M(2016)Vienna Consensus Conference, p.: ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site Neuroendocrinology 103 172-185
[3]
Lipsitz S(2005)Eastern Cooperative Oncology, G.: Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281 J. Clin. Oncol. 23 4897-4904
[4]
Hahn RG(1984)Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor J. Clin. Oncol. 2 1255-1259
[5]
Klaassen D(2015)Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms–Predictive and Prognostic Markers for Treatment Stratification PLoS ONE 10 1253-1262
[6]
Pavel M(2015)Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours Eur. J. Cancer 51 345-353
[7]
O’Toole D(2016)Streptozocin and 5-Fluorouracil for the Treatment of Pancreatic Neuroendocrine Tumors: Efficacy, Prognostic Factors and Toxicity Neuroendocrinology 103 228-247
[8]
Costa F(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur. J. Cancer 45 805-835
[9]
Capdevila J(2007)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration Epidemiology 18 514-523
[10]
Gross D(2011)Rad001 in Advanced Neuroendocrine Tumors, T.T.S.G.: Everolimus for advanced pancreatic neuroendocrine tumors N. Engl. J. Med. 364 501-513